Related content

CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance

By  

Acta Haematologica, Vol. 135, Iss. 1, 2015-0 ,pp. : 11-14

Karger

Access to resources Recommend Favorite

Bone Marrow Angiogenesis and Plasma Cell Angiogenic and Invasive Potential in Patients with Active Multiple Myeloma

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 162-169

Karger

Access to resources Recommend Favorite

Molecular Cytogenetic Aberrations in Tunisian Patients with Multiple Myeloma Identified by cIg-FISH in Fixed Bone Marrow Cells

By  

Cytogenetic and Genome Research, Vol. 136, Iss. 1, 2011-12 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Hyaluronan, a major non‐protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 259-269

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of skeletal morbidity rates over time in patients with multiple myeloma-related bone disease as reported in randomized trials employing bone-modifying agents

By Poon Michael   Zeng Liang   Zhang Liying   Hsiao Janey   Wong Erin   Lam Henry   Bedard Gillian   Chow Edward  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 1, 2013-01 ,pp. : 69-76

Future Medicine

Access to resources Recommend Favorite